Baclofen toxicity

Revision as of 16:37, 5 November 2025 by Rossdonaldson1 (talk | contribs)

Background

Tablets of Baclofen
  • Baclofen is a synthetic derivative of GABA used to reduce spasticity in conditions such as multiple sclerosis and cerebral palsy, or to reduce muscular spasm in lower back pain.[1]
  • At therapeutic doses, baclofen acts as a GABA-B receptor agonist in the spinal cord, causing inhibition of muscular tone.
  • At higher doses, baclofen loses selectivity and can cause sedation.
  • Primarily (80%) excreted by the kidneys
    • Dosage must be reduced in renal dysfunction and should be avoided with GFR < 30 mL/min/1.73 m2.
    • Patients on chronic therapy may become toxic with new AKI.

Clinical Features

Differential Diagnosis

Sedative/hypnotic toxicity

Also consider co-ingestion with intentional overdose

Evaluation

  • Diagnosis of exclusion, based on history
    • Baclofen level can be measured but is not clinically useful
  • In patients with intrathecal baclofen pump:
    • Obtain KUB to evaluate pump tubing integrity and placement
    • Consult the managing specialist to interrogate pump

Management

  • Activated charcoal for recent ingestion
  • Supportive care:
    • Respiratory support[3]
    • IV fluids
    • Vasopressors for persistent hypotension
    • Benzodiazepines for seizures or severe myoclonus
      • CNS depressive effects of benzodiazepines will be increased
      • Use the lowest effective dose and be prepared for respiratory depression
  • Hemodialysis for very severe toxicity
    • Probably not beneficial in patients with normal renal function
  • For patients with intrathecal pump:[4]
    • Consult managing specialist
    • Turn off pump
    • Can remove baclofen from pump reservoir and replace with normal saline
    • Consider large volume CSF removal via lumbar puncture to reduce level

Disposition

  • Admit for monitoring until back to neurologic baseline
  • ICU for severe coma, seizures, airway compromise, or respiratory failure

See Also

External Links

References

  1. Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
  2. Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82
  3. *Dease NM, et al. Baclofen Toxicity. Updated 2023 Mar 20. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK580550. Accessed Oct 13, 2025.
  4. Watve SV, et al. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012 Feb;50(2):107-11. doi: 10.1038/sc.2011.112